Literature DB >> 21987521

Exclusion of the uniform tetraploid cells significantly improves specificity of the urine FISH assay.

Neda A Moatamed1, Sophia K Apple, Carol J Bennett, William J Aronson, Ivana Klisak, Bobbi-Jo Shirley, Farhad Moatamed.   

Abstract

The urine fluorescence in situ hybridization (FISH) assay (UroVysion™), with the current scoring criteria, has a higher sensitivity than routine cytopathology but a lower specificity. Among 215 urine FISH tests we performed, 45 had associated histopathology and clinical follow up. In this study, a cell with four signals for each probe was classified as a uniform tetraploid cell (UTC); a presumed reparative cell which is currently classified as an abnormal cell in the FDA approved assay. By using the existing criteria, the tests were scored as positive or negative before and after exclusion of the UTCs. Before the exclusion, 24 positive, 13 negative, seven false positive, and one false negative result were obtained with 96% sensitivity and 65% specificity. After the exclusion, the results changed to 22 positive, 19 negative, one false positive, and three false negatives resulting in a 88% sensitivity of 88% and a 95% specificity; a significant improvement in the specificity. We conclude that exclusion of the UTCs as abnormal cells would result in a more solid performance of the FISH assay.
Copyright © 2011 Wiley Periodicals, Inc.

Mesh:

Year:  2011        PMID: 21987521     DOI: 10.1002/dc.21831

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

1.  Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization.

Authors:  Johannes Mischinger; Lutz Philipp Guttenberg; Jörg Hennenlotter; Georgios Gakis; Stefan Aufderklamm; Steffen Rausch; Eva Neumann; Jens Bedke; Stefan Kruck; Christian Schwentner; Arnulf Stenzl; Tilman Todenhöfer
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-02       Impact factor: 4.553

2.  Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.

Authors:  Haythem Dimashkieh; Daynna J Wolff; T Michael Smith; Patricia M Houser; Paul J Nietert; Jack Yang
Journal:  Cancer Cytopathol       Date:  2013-06-25       Impact factor: 5.284

3.  Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens.

Authors:  Sue Chang; Elaine Smith; Mary Levin; Jian-Yu Rao; Neda A Moatamed
Journal:  Cytojournal       Date:  2015-01-22       Impact factor: 2.091

4.  One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection.

Authors:  Rima Tinawi-Aljundi; Lauren King; Shannon T Knuth; Michael Gildea; Carrie Ng; Josh Kahl; Jacqueline Dion; Chris Young; Edward W Schervish; J Rene Frontera; Jason Hafron; Kenneth M Kernen; Robert Di Loreto; Joan Aurich-Costa
Journal:  Res Rep Urol       Date:  2015-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.